Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Study 1501: Healthy Male and Female Participants

    Research Purpose: Study 1416 is designed to evaluate an investigational drug being developed for the treatment of certain types of skin conditions. Participants will receive one of two different formulations of the investigational drug which will be given one time as a subcutaneous injection (just under the skin).  The following will be evaluated and compared:

    • How quickly the body processes and eliminates each the different investigational drug formulations.
    • The safety/tolerability of the different investigational drug formulations.

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women are allowed to participate

    Age

    18-65 years

    Weight

    Between 154-198 pounds

    Tobacco/Nicotine Use

    No use of tobacco/nicotine containing products while at Prism.  Use of tobacco/nicotine at all other times is allowed. 

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications not listed below

    Allowed Medications

    Prescribed hormonal birth control, low dose aspirin, vitamins, and nutritional supplements are allowed

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 8 ½ weeks. 

    Inpatient Stay

    • Participants will admit for an inpatient stay at Prism Clinical Research 1 time.
    • The inpatient stay will last approximately 24 hours

    Outpatient Visits

    • There are at total of  11 outpatient visits
    • The outpatient visits will last between approximately 30-60 minutes

     

    Compensation: Up to $1,775.00

  • Study 1418: Healthy Male and Female Particpants

    Research Purpose: Study 1418 is designed to evaluate an investigational drug being developed for the treatment of influenza. Participants will receive twice daily, oral doses of the investigational drug or a placebo.  The following will be evaluated:

    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolerability of the investigational drug
    • The male reproductive safety of the investigational drug  

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate; males who have a vasectomy cannot participate.

    Females

    Women are allowed to participate

    Age

    18-65 years

    Body Mass Index (BMI)

    Greater than or equal to 16 kg/m²

    Weight

    Greater than or equal to 96.8 pounds

    Tobacco/Nicotine Use

    No tobacco/nicotine use in the 3 months prior to the start of the study until study completion of the study

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 2 years before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements not listed below

    Allowed Medications

    Prescribed/stable hormonal birth control is allowed

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 7 weeks.

    Inpatient Stays

    • Participants will admit for an inpatient stay at Prism Clinical Research 1 time.
    • The inpatient stay will last approximately 3 weeks (22 overnights)

    Outpatient Visits

    • There is one outpatient visit and one follow-up phone call.
    • The outpatient visit will last between approximately 2 hours
    • MALES ONLY: based on laboratory results, some males may be required to return for 1-3 additional outpatient visits.  For these participants, the study time commitment may be as long as 16 weeks. Additional compensation will be provided for completion of these visits.

     

    Compensation: Up to $5,575.00

Recruitment and Volunteer Demographics

Prism Clinical Research recognizes the need to continually grow our diverse volunteer database populations. Through a multi-faceted enrollment process that includes a dedicated recruitment department, collaborative physician partnerships, advertising and subject referral programs, Prism Clinical Research can deliver Phase I-II results in the following populations:

  • HIV

  • Hepatic

  • Renal (Pre-ESRD, ESRD)

  • Type 2 Diabetes

  • Obesity

  • Healthy Male/Female/Elderly

  • Gilbert’s subset

  • Rheumatoid Arthritis

  • Epilepsy

  • Multiple Sclerosis
  • GI (IBS & Crohn’s)

  • Celiac
  • COPD, Allergy and Asthma

  • High Cholesterol

  • Hypertensive

  • Alzheimer's Disease
  • Ophthalmology

  • Slow Metabolizers

  • Osteoporosis
  • Osteoarthritis
  • Lupus

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel